Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array.
暂无分享,去创建一个
L. Magder | V. Rus | I. Luzina | S. Atamas | F. Selaru | V. Shustova | Laurence S Magder | Sergei P Atamas | Violeta Rus | Valentina Shustova | Irina G Luzina | Florin Selaru | Charles S Via | C. Via
[1] J. Gray,et al. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. , 1998, Journal of immunology.
[2] P. Surányi,et al. Correlations of Monocyte Phagocytic Receptor Expressions with Serum Immune Complex Level in Systemic Lupus Erythematosus , 1994, Scandinavian journal of immunology.
[3] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[4] Katsuaki Sato,et al. Chemokine Receptor Expressions and Responsiveness of Cord Blood T Cells , 2001, The Journal of Immunology.
[5] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[6] A. Custovic,et al. Apoptosis signals in atopy and asthma measured with cDNA arrays , 2001, Clinical and experimental immunology.
[7] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[8] J. Trent,et al. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays , 1999 .
[9] M. Weller,et al. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells , 2000, Cell Death and Differentiation.
[10] A. Zernecke,et al. Combinatorial Model of Chemokine Involvement in Glomerular Monocyte Recruitment: Role of CXC Chemokine Receptor 2 in Infiltration During Nephrotoxic Nephritis1 , 2001, The Journal of Immunology.
[11] M. Liang,et al. Measurement of systemic lupus erythematosus activity in clinical research. , 1988, Arthritis and rheumatism.
[12] R. W. Davis,et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Spring,et al. Urokinase‐type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix , 1994, Journal of leukocyte biology.
[14] K. Miura,et al. Quantitative assessment of DNA microarrays--comparison with Northern blot analyses. , 2001, Genomics.
[15] Ronald W. Davis,et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.
[16] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.
[17] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Gygi,et al. Correlation between Protein and mRNA Abundance in Yeast , 1999, Molecular and Cellular Biology.
[20] T. Vischer,et al. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. , 1997, The Journal of rheumatology.
[21] Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus. , 1997, British journal of rheumatology.
[22] Eric J. Kunkel,et al. CCR7 Expression and Memory T Cell Diversity in Humans1 , 2001, The Journal of Immunology.
[23] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] YOUHAI H. Chen,et al. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression , 2000, The Journal of experimental medicine.
[25] B. Hilliard,et al. Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[26] M. Arima,et al. Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone. , 1999, American journal of respiratory cell and molecular biology.
[27] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Krammer,et al. Surface expression of TRAIL/Apo‐2 ligand in activated mouse T and B cells , 1998, European journal of immunology.
[29] C. Marsh,et al. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra). , 1996, Cytokine.
[30] B. Groner,et al. Cooperation Among Stat1, Glucocorticoid Receptor, and PU.1 in Transcriptional Activation of the High-Affinity Fcγ Receptor I in Monocytes1 , 2000, The Journal of Immunology.
[31] P. Allavena,et al. Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes1 , 2000, The Journal of Immunology.
[32] K. Resch,et al. Effects of IL‐1 receptor accessory protein on IL‐1 binding , 1998, FEBS Letters.
[33] M. Goto,et al. Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue diseases. , 1991, Annals of the rheumatic diseases.
[34] Kenichi Watanabe,et al. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus , 1989, Journal of Clinical Immunology.
[35] H. Euler,et al. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections. , 1997, The Journal of rheumatology.
[36] S. Zucker,et al. Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity. , 1999, The Journal of rheumatology.
[37] N. Young,et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. , 2000, Blood.
[38] I. Herr,et al. TRAIL/Apo‐2‐ligand‐induced apoptosis in human T cells , 1998, European journal of immunology.
[39] S. Nisole,et al. Inhibition of HIV infection by the cytokine midkine. , 2001, Virology.
[40] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[41] A. Tsirogianni,et al. Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α Levels and Disease Acitivity in Systemic Lupus Erythematosus , 1999, Clinical Rheumatology.
[42] S. Durham,et al. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment. , 1997, The Journal of allergy and clinical immunology.